Project Grant R01AI165656
Award Date
7/17/24
Completion Date
6/30/25
Dollars Obligated
$871K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
This Project Grant award of $838,320.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the grant is to conduct research to define the genetic network in the fungus Aspergillus fumigatus that mediates its ability to cause invasive aspergillosis infections, particularly in the context of patients receiving Bruton's tyrosine kinase (BTK) inhibitor therapies for cancer. The...
The federal Project Grant award R21AI190747, totaling $249,749.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant supports research by the University of Iowa to develop a new approach for analyzing the transcriptional control of virulence in the human fungal pathogen Aspergillus fumigatus. The research aims to enable time-dependent proteolytic removal of key transcription...
This $300,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to discover and develop new, more potent antifungal therapies for treating invasive fungal infections such as cryptococcosis, candidiasis, and aspergillosis. The funding will support the continued screening of chemical libraries to identify lead compounds that selectively inhibit the fungal ceramide synthase 1...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $181,861 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Duke University. The grant supports research to develop novel, non-invasive diagnostic and prognostic biomarkers for invasive aspergillosis (IA) based on host transcriptional responses. The key objectives are to: Derive and optimize a diagnostic host gene expression signature for IA from a large sample repository. Enroll...
This Project Grant award of $750,815, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports research aimed at developing novel anti-infective strategies to treat pulmonary mucormycosis, a deadly invasive fungal infection. The key objectives are to: 1) examine the role of the host cell hypoxia-response pathway, specifically the protein ANGPTL4, in the pathogenesis of mucormycosis and explore its therapeutic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $642,775 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis. The funding will support research to accelerate the discovery of novel antifungal peptides using one-bead one-compound (OBOC) combinatorial technology. The project aims to develop a high-throughput screening platform to identify membrane-active antifungal peptides that can effectively...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research program provides $170,000.00 to Prokaryotics Incorporated, a pharmaceutical research company, to perform structure-based design of novel antifungal inhibitors targeting the glycosylphosphatidylinositol (GPI) ethanolamine phosphate transferase, MCD4. The research aims to develop mechanistically novel antifungal agents to address...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $782,178 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation For The State University Of New York, doing business as Stony Brook University. The grant, awarded on June 12, 2025, supports the development of new antifungal agents targeting the sterylglucosidase (SGL1/SGLA) enzymes found in pathogenic fungi like Cryptococcus neoformans and Aspergillus...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $558,747 to Texas Tech University Health Sciences Center (TTUHSC) to conduct research on a novel link between calcineurin, amino acid permease, and protein kinase A in the virulence of the fungus Mucor, which causes the life-threatening condition mucormycosis. The 5-year project aims to identify key transcription...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $494,696 to The University of Texas Health Science Center at San Antonio to conduct research on translational control mechanisms regulating Candida albicans morphology, stress responses, and virulence. The research aims to determine how the ASC1 and EIF4E-binding proteins function together to modulate the EIF4F...